EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Incidence and prognosis of subclinical cardiac perforation after leadless pacemaker implantation

Y Lee, J S Uhm, M H Kim, J W Park, D Kim, H T Yu, T H Kim, B J, H N Pak, M H Lee

Europace · 24.05.2024 · 26 (Supplement_1)

DOI: 10.1093/europace/euae102.520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, online erschienen am 24.05.2024. Verfasst von Y Lee und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Subclinical cardiac perforation, a known complication of cardiac implantable electronic device leads, occurs in 6–20% of cases. While leadless pacemakers are advised to be placed in the septum to mitigate perforation risk, limited studies exist on lead positioning and perforation incidence.

Objectives

This retrospective observational study aimed to assess leadless pacemaker lead positions, determine the incidence of subclinical cardiac perforation, and evaluate associated prognoses through computed tomography (CT) in post-implantation patients.

Methods

Thirty-one patients underwent CT after leadless pacemaker implantation. Two cardiologists and a radiologist analyzed CT scans to categorize lead positions (septum, free wall, or septum-free wall junction) and identify subclinical perforation (defined as tine transversal beyond the outer myocardial contour without symptoms, hemodynamic instability, or pacemaker issues).

Results

Mean age at implantation was 70.5 ± 12.7 years; 35.5% were male, and 41.9% had atrial fibrillation. Twenty patients (64.5%) were on anticoagulants or antiplatelet agents. Twenty-four patients (77.4%) were positioned at the septum-free wall junction. Subclinical perforation occurred in 12 patients (38.7%), with a higher proportion in patients on non-vitamin K antagonist oral anticoagulants. Two patients had moderate amount of pericardial effusion; the remaining ten with subclinical perforation were stable during follow-up.

Conclusions

The most common leadless pacemaker implantation site was the septum-free wall junction with 38.7% of subclinical perforation.

Zitieren

APA

Lee, Y., Uhm, J. S., Kim, M. H., Park, J. W., Kim, D., Yu, H. T., Kim, T. H., J, B., Pak, H. N., & Lee, M. H. (2024). Incidence and prognosis of subclinical cardiac perforation after leadless pacemaker implantation. Europace, 26(Supplement_1). https://doi.org/10.1093/europace/euae102.520

Vancouver

Lee Y, Uhm JS, Kim MH, Park JW, Kim D, Yu HT, et al. Incidence and prognosis of subclinical cardiac perforation after leadless pacemaker implantation. Europace. 2024;26(Supplement_1). doi:10.1093/europace/euae102.520

BibTeX
@article{Lee2024,
  author = {Lee, Y and Uhm, J S and Kim, M H and Park, J W and Kim, D and Yu, H T and Kim, T H and J, B and Pak, H N and Lee, M H},
  title = {Incidence and prognosis of subclinical cardiac perforation after leadless pacemaker implantation},
  journal = {Europace},
  year = {2024},
  volume = {26},
  number = {Supplement_1},
  doi = {10.1093/europace/euae102.520}
}
Kostenlos starten →